International Journal of Drug Delivery Technology
Volume 14, Issue 2

Novel Proniosomes of Manidipine: Optimization and In-vivo Evaluation

J Ashwini, Vasudha Bakshi*

Department of Pharmaceutics, School of Pharmacy, Anurag University, Hyderabad, Telangana, India. 

Received: 27th November, 2023; Revised: 19th March, 2024; Accepted: 23nd April, 2024; Available Online: 25th June, 2024 

ABSTRACT

The objective of the current study is to produce proniosomes of manidipine using the thin film hydration method for the management of hypertension. Statistical optimization was performed using the Box-Behnken design. The generated formulations were tested for particle size, entrapment effectiveness, and drug release at 12 hours. The improved proniosomes were further assessed for surface morphology, ATR, and differential scanning calorimetry (DSC). The improved proniosomes were also assessed for an in-vitro and in-vivo investigation on dexamethasone-induced hypertension. It was noted that there was no significant interaction with excipients. DSC indicated a considerable shift in the endothermal peak and showed interaction with the study’s excipients. Niosomes and drug crystals were seen to be dispersed in small areas during the scanning electron microscope (SEM) analysis. The study also showed that the optimized proniosomes have asymmetrical surfaces and appearances. The zeta value in the research was -6.7 mV, indicating stability. According to the optimized proniosomes formulation, F14 released 99.97% of the drug at its highest concentration in 12 hours. ANOVA results from an in-vivo investigation confirmed a satisfactory outcome in decreasing raised blood pressure, as shown by the F and p-values.

Keywords: Manidipine, Proniosomes, Zeta potential, Niosomes dexamethasone. International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.2.03

How to cite this article: Ashwini J, Bakshi V. Novel Proniosomes of Manidipine: Optimization and In-vivo Evaluation. International Journal of Drug Delivery Technology. 2024;14(2):630-638.

REFERENCES

  1. Pham TT, Jaafar-Maalej C, Charcosset C, Fessi H. Liposome and niosome preparation using a membrane contactor for scale-up. Colloids and Surfaces B: Biointerfaces. 2012 Jun; 94:15–21.
  2. Janga KY, Jukanti R, Velpula A, Sunkavalli S, Bandari S, Kandadi P, et al. Bioavailability enhancement of zaleplon via proliposomes: Role of surface charge. European Journal of Pharmaceutics and Biopharmaceutics. 2012 Feb;80(2):347–57.
  3. Payne NI, Browning I, Hynes CA. Characterization of Proliposomes. Journal of Pharmaceutical Sciences. 1986 Apr;75(4):330–3.
  4. Om Prakash Katare, Vyas SP, Dixit VK. Effervescent granule based proliposomes of ibuprofen. 1990 Jan 1;7(4):455–62.
  5. Baillie Aj, Florence At, Hume Lr, Muirhead Gt, Rogerson The preparation and properties of niosomes-non-ionic surfactant vesicles. Journal of Pharmacy and Pharmacology. 1985 Dec;37(12):863–8.
  6. Schreier, H., & Bouwstra, J. (1994). Liposomes and niosomes as topical drug carriers: Dermal and transdermal drug delivery. Journal of Controlled Release, 30(1), 1-15. https://doi. org/10.1016/0168-3659(94)90039
  7. Solanki AB, Parikh JR, Parikh RH. Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level box-behnken design. AAPS Pharm SciTech. 2007 Oct;8(4).
  8. Ge X, Wei M, He S, Yuan WE. Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery. Pharmaceutics. 2019 Jan 29;11(2):55.
  9. Uchegbu, I. F., & Vyas, S. P. (1998). Non-ionic surfactant based vesicles (niosomes) in drug delivery. International Journal of Pharmaceutics, 172(1-2), 33-70.
  10. Carafa M, Santucci E, Lucania G. Lidocaine-loaded non- ionic surfactant vesicles: characterization and in-vitro permeation studies. International Journal of Pharmaceutics. 2002 Jan;231(1):21–32.
  11. Alsarra IA, Bosela AA, Ahmed SM, Mahrous GM. Proniosomes as a drug carrier for transdermal delivery of ketorolac. European Journal of Pharmaceutics and Biopharmaceutics. 2005 Apr;59(3):485–90.
  12. Proniosomes: A Novel Drug Carrier Preparation. International Journal of Pharmaceutics 1999 ;185(1):23–35.
  13. Radha GV, Rani TS, Sarvani B. A review on proniosomal drug delivery system for targeted drug action. Journal of Basic and Clinical Pharmacy [Internet]. 2013 Mar 1;4(2):42–8.
  14. Patel NN, Roopchandani KV, Gupta A, Gupta A. Proniosomes for better transdermal drug delivery: A review, J Pharmacy Research,2013; 62–80.
  15. Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. International Journal of Pharmaceutics. 2008 Sep;361(1- 2):104–11.